A novel bone metastasis-related gene signature for predicting prognosis, anti-androgen resistance, and drug choice in prostate cancer
BMRPS facilitates the prediction of prognosis and resistance to anti-androgens in PCa. It also offers insights into the molecular mechanisms of bone metastasis and aids in drug selection for the treatment of PCa.
Authors
- Xiaoqi Deng
- Zhangcheng Liu (ORCID: https://orcid.org/0000-0001-5208-5083)
- Liangdong Song
- Shuai Su (ORCID: https://orcid.org/0000-0002-1648-0817)
- Chengcheng Wei (ORCID: https://orcid.org/0000-0002-6634-0572)
- Delin Wang (ORCID: https://orcid.org/0000-0003-0689-3199)
- Yu Luo (ORCID: https://orcid.org/0000-0002-0711-2385)
- Kun Han (ORCID: https://orcid.org/0000-0001-9272-5567)
- Jindong Zhang (ORCID: https://orcid.org/0000-0002-5660-1281)
- Yunfan Li (ORCID: https://orcid.org/0009-0002-6349-4688)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of bone oncology
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1016/j.jbo.2025.100673
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04